What is Vir Biotechnology, Inc.'s capex?

Vir Biotechnology, Inc. (VIR) reported capex of $390K in Q1 2026.

How has Vir Biotechnology, Inc.'s capex changed year-over-year?

Vir Biotechnology, Inc.'s capex decreased by 76.1% year-over-year, from $1.63M to $390K.

What is the long-term trend for Vir Biotechnology, Inc.'s capex?

Over 4 years (2021 to 2025), Vir Biotechnology, Inc.'s capex has grown at a -31.4% compound annual growth rate (CAGR), from $21.82M to $4.83M.

What does capex mean?

Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.

Vir Biotechnology, Inc. VIR CapEx

CapEx at other companies

AmgenAMGN

$712M+73.2%

Regeneron PharmaceuticalsREGN

$230.6M+0.6%

Gilead SciencesGILD

$117M+12.5%

Viridian Therapeutics, Inc.VRDN

$23K-73.3%

Iovance Biotherapeutics, Inc.IOVA

$6.61M+6.4%

Nuvation BioNUVB

$48K-33.3%

Other financials

Income statement

See full

Revenue-$29.0K-101%

Gross profit$1.2M-60.2%

Operating income-$132.3M+5.2%

Net income-$125.7M-3.9%

EPS (diluted)-$0.85+3.4%

Balance sheet

See full

Cash & equivalents$283.0M-23.1%

Total debt$95.6M-0.5%

Total equity$812.8M-22.1%

Total assets$1.0B-21.6%

Cash flow

See full

Operating cash flow-$132.4M-69.5%

Free cash flow-$132.8M-66.5%

Valuation

See full

Market cap$1.71B+61.1%

Enterprise value$1.53B+102%

P/S26.2×-24.8×

Profitability

See full

Gross margin96.1%-2.7pp

Operating margin-720.8%-313pp

Net margin-676%-291pp

FCF margin-686.5%-273pp

Returns & leverage

See full

Return on equity-47.7%+3.6pp

Debt / equity0.1×0.0×

Current ratio7.1×+0.3×

Where this comes from

Reported directly by Vir Biotechnology, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vir Biotechnology, Inc.'s capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Vir Biotechnology, Inc.'s capex?: Vir Biotechnology, Inc. (VIR) reported capex of $390K in Q1 2026.
How has Vir Biotechnology, Inc.'s capex changed year-over-year?: Vir Biotechnology, Inc.'s capex decreased by 76.1% year-over-year, from $1.63M to $390K.
What is the long-term trend for Vir Biotechnology, Inc.'s capex?: Over 4 years (2021 to 2025), Vir Biotechnology, Inc.'s capex has grown at a -31.4% compound annual growth rate (CAGR), from $21.82M to $4.83M.
What does capex mean?: Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.